Bottazzi M - Search Results

1

[Biological damage and income loss in the Italian legislation for the compensation of occupational diseases: critical considerations].

Bottazzi M, Cassina G. Bottazzi M, et al. G Ital Med Lav Ergon. 2012 Jul-Sep;34(3 Suppl):471-3. G Ital Med Lav Ergon. 2012. PMID: 23405693 Italian.

2

[Immigration, work and health--social, cultural and best practices in occupational medicine: the views of union patronage].

Bottazzi M, Della Torre L. Bottazzi M, et al. G Ital Med Lav Ergon. 2011 Apr-Jun;33(2 Suppl):29-32. G Ital Med Lav Ergon. 2011. PMID: 22187920 Italian.

3

[Insurance coverage in repetitive strain injury of the upper limbs as provided by the National Insurance Institute for Occupational Diseases].

Bracci C, Bottazzi M. Bracci C, et al. Among authors: bottazzi m. Med Lav. 1996 Nov-Dec;87(6):773-7. Med Lav. 1996. PMID: 9148132 Italian.

4

[Insurance against occupational cancer in Italy and in Europe].

Bottazzi M. Bottazzi M. Epidemiol Prev. 2009 Jul-Oct;33(4-5 Suppl 2):85-93. Epidemiol Prev. 2009. PMID: 20124648 Free article. Italian.

5

[A systeM of occupational tumor registration: experience of the National INCA].

Bottazzi M, Bracci C, Comba P, Pirastu R, Masina A. Bottazzi M, et al. Med Lav. 1992 Jul-Aug;83(4):381-2. Med Lav. 1992. PMID: 1461195 Italian. No abstract available.

6

[The work of the social security and welfare branch of the Trade Union supporting workers suffering from mesothelioma and asbestos related diseases].

Bottazzi M. Bottazzi M. Epidemiol Prev. 2007 Jul-Aug;31(4 Suppl 1):31-4. Epidemiol Prev. 2007. PMID: 18050856 Free article. Italian. No abstract available.

7

The zebrafish as a potential model for vaccine and adjuvant development.

Hotez PJ, Bottazzi ME, Islam NY, Lee J, Pollet J, Poveda C, Strych U, Thimmiraju SR, Uzcategui NL, Versteeg L, Gorelick D. Hotez PJ, et al. Among authors: bottazzi me. Expert Rev Vaccines. 2024 Jan-Dec;23(1):535-545. doi: 10.1080/14760584.2024.2345685. Epub 2024 May 9. Expert Rev Vaccines. 2024. PMID: 38664959 Free article. Review.

8

What is the economic benefit of annual COVID-19 vaccination from the adult individual perspective?

Bartsch SM, O'Shea KJ, Weatherwax C, Strych U, Velmurugan K, John DC, Bottazzi ME, Hussein M, Martinez MF, Chin KL, Ciciriello A, Heneghan J, Dibbs A, Scannell SA, Hotez PJ, Lee BY. Bartsch SM, et al. Among authors: bottazzi me. J Infect Dis. 2024 Apr 6:jiae179. doi: 10.1093/infdis/jiae179. Online ahead of print. J Infect Dis. 2024. PMID: 38581432

9

The potential epidemiologic, clinical, and economic value of a universal coronavirus vaccine: a modelling study.

Bartsch SM, O'Shea KJ, John DC, Strych U, Bottazzi ME, Martinez MF, Ciciriello A, Chin KL, Weatherwax C, Velmurugan K, Heneghan J, Scannell SA, Hotez PJ, Lee BY. Bartsch SM, et al. Among authors: bottazzi me. EClinicalMedicine. 2024 Jan 11;68:102369. doi: 10.1016/j.eclinm.2023.102369. eCollection 2024 Feb. EClinicalMedicine. 2024. PMID: 38545093 Free PMC article.

10

Harnessing RNA Technology to Advance Therapeutic Vaccine Antigens against Chagas Disease.

Mancino C, Pollet J, Zinger A, Jones KM, Villar MJ, Leao AC, Adhikari R, Versteeg L, Tyagi Kundu R, Strych U, Giordano F, Hotez PJ, Bottazzi ME, Taraballi F, Poveda C. Mancino C, et al. Among authors: bottazzi me. ACS Appl Mater Interfaces. 2024 Apr 3;16(13):15832-15846. doi: 10.1021/acsami.3c18830. Epub 2024 Mar 22. ACS Appl Mater Interfaces. 2024. PMID: 38518375

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

279 results

Search Page